FIRST TRACKS BIOTHERAPEUTICS, INC. (TRAX) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$34.83M*; Operating income -$34.94M; Depreciation and amortization $105.00K*.
- 2026-03-31: Basis Reported; EBITDA -$52.69M; Operating income (m); Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA -$45.76M*; Operating income -$45.90M; Depreciation and amortization $142.00K*.
- 2025-03-31: Basis Reported; EBITDA -$51.13M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2025-03-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$34.83M* | -$34.94M | $105.00K* | (m) | (m) | $25.00K* | -$31.92M* | (m) | $25.64M | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$52.69M | (m) | (m) | (m) | (m) | $17.00K | -$32.56M | (m) | $33.95M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$45.76M* | -$45.90M | $142.00K* | (m) | (m) | $39.00K* | -$38.64M* | (m) | $39.27M | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$51.13M | (m) | (m) | (m) | (m) | $35.00K | -$45.01M | (m) | $41.47M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|